findmyKOL

Roumen Balabanov, MD

Basic profile

University of Chicago

ORCIDNPI
RegionChicago, IL · MidwestSpecialtyNeurologyFocusNeurology
Last active 2009findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPaymentsNone reportedNIH funding2005–2009Why? →

Roumen Balabanov is a Neurology physician affiliated with University of Chicago. OpenAlex indexes 26 publications with 684 citations (h-index 10).

Overview

Scholarship

indexed output and impact (OpenAlex)
26publications

Distinct works indexed by OpenAlex, matched via ORCID.

684citations

Total citations across indexed works.

10h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1NIH grants · 2005–2009

Federally funded research awards.

View funding

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    94.9%
    CD20-directed Cytolytic Antibody93.7%
    Ocrelizumab100%
    Part B, office-administered18 patients
    Other immunosuppressants0.9%
    Dimethyl Fumarate38%Tecfidera36%Vumerity26%
    Part D<11 patients

    + 2 more classes in this area

  • Nervous system

    2.6%
    Benzodiazepine0.8%
    Diazepam47%Clonazepam37%Alprazolam16%
    Part D<11 patients
    Potassium Channel Blocker0.5%
    Dalfampridine Er100%
    Part D12 patients

    + 7 more classes in this area

  • Dermatology

    1.2%
    Corticosteroid1.2%
    Methylprednisolone sodium succinate88%Methylprednisolone12%
    Part D + Part B32 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

1 NIH research award on record, funded 20052009 per NIH RePORTER. The latest:

3 more award records behind the reveal.Reveal →

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”